Applicability and Potentiality of Stereotactic Body Radiotherapy in Management of Hepatocellular Carcinoma_Juniper Publishers
ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY JUNIPER PUBLISHERS Authored by Beltagi M Introduction Hepatocellular carcinoma (HCC) represents 80 to 90 percent of primary liver malignancy. It is the fifth most common cancer in the world, and the third most common cause of cancer related death, so it is considered as a major health problem worldwide [ 1 ]. Non-surgical strategies for tumor ablation as transarterial chemoembolization (TACE), radiation therapy, and radioembolization are alternatives for patients who are not candidates for surgical resection or liver transplantation, and whose tumor is either too large or multifocal for a local ablation [ 2 ]. Aim of the Work The aim of this work is First: To evaluate the response of the tumor to radiotherapy in patients with Barcelona Clinic Liver Cancer (BCLC) stage A, B, and C of HCC based on modified Response Evaluation Criteria In Solid Tumor (mRECIST)....